Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors - Join Clinical Trial NCTNCT06276491
How to Join This Clinical Trial - NCTNCT06276491
Learn how to participate in this PHASE1 trial studying an investigational therapy for Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor, Testicular Germ Cell Tumor, Ovarian Germ Cell Tumor. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor, Testicular Germ Cell Tumor, Ovarian Germ Cell Tumor. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor, Testicular Germ Cell Tumor, Ovarian Germ Cell Tumor
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE1 - Early safety study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT06276491 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 9 locations. Find a study site near you:
Clinical Research Site
Atlanta, Georgia 30322 - United States
Status: RECRUITING
Clinical Research Site
Detroit, Michigan 48201 - United States
Status: RECRUITING
Clinical Research Site
Hackensack, New Jersey 07601 - United States
Status: RECRUITING
Clinical Research Site
Bronx, New York 10461 - United States
Status: RECRUITING
Clinical Research Site
New York, New York 10029 - United States
Status: RECRUITING
Clinical Research Site
Columbus, Ohio 43210 - United States
Status: RECRUITING
Clinical Research Site
Oklahoma City, Oklahoma 73104 - United States
Status: RECRUITING
Clinical Research Site
Nashville, Tennessee 37203 - United States
Status: RECRUITING
Clinical Research Site
Charlottesville, Virginia 22903 - United States
Status: RECRUITING
How to Enroll in This Study
To learn more about participating in this PHASE1 clinical trial for Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor, Testicular Germ Cell Tumor, Ovarian Germ Cell Tumor:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships